Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (241-250 of 1,365) with videos related to

Pageof 137
Sort By:
Ejhaem|January 31, 2023
Supply chain disruptions due to the SARS-CoV-2 pandemic lead to an unusual preanalytical error in measuring hemoglobin concentration in a large medical centerSamuel M Law, Rochelle Hardy, Danna Anderson, et al.
Ejhaem|July 21, 2025
Isolated Mu Heavy Chain Deposition Disease-A Rare Cause of Spontaneous Splenic Rupture in a Young AdultSwe Swe Hlaing, Gabor Varadi, Alexi Bloom, et al.
Ejhaem|November 24, 2025
Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple MyelomaGrace M Ferri, Cenk Yildirim, Nhan V Do, et al.
Ejhaem|November 28, 2025
Alternative 5-Azacitidine 5-Day 100 mg/m<sup>2</sup> Dosage Shows Non-Inferiority to Classical Schedule for Myelodysplastic Neoplasm (MDS) and Chronic Myelomonocytic Leukaemia (CMML) TreatmentGerasimos Tsilimidos, Filipe Martins, Mariangela Costanza, et al.
Ejhaem|November 3, 2025
T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia After CAR-T TherapyNobuhisa Takahashi, Kazuhiro Mochizuki, Tomoko Waragai, et al.
Ejhaem|October 27, 2025
Epcoritamab for Relapsed/Refractory EBV+ Post-Transplant Lymphoproliferative Disorder of DLBCL-TypeLi Yuan Chan, Simon O'Connor, Dima El-Sharkawi, et al.
Ejhaem|October 27, 2025
Successful Treatment of Refractory IgA-Mediated Autoimmune Hemolytic Anemia With BortezomibSilvia Neri, Corien L Eckhardt, Boukje M Beuger, et al.
Ejhaem|October 23, 2025
Correction to "Targeted Degradation of Class 1 HDACs With PROTACs is Highly Effective at Inducing DLBCL Cell Death"
Ejhaem|October 30, 2025
Secondary Malignancies Following CAR T-Cell Therapy for B-Cell Malignancies: A Retrospective AnalysisJoanne Britto, Audrey Y H Dong, Gregory Pond, et al.
Ejhaem|October 6, 2025
Insights Into Hemoglobinopathies in Spain: A Comprehensive ReviewJoan-Lluis Vives Corrons
Pageof 137

Showing results (241-250 of 1,365) with videos related to

Sort By:
Pageof 137
Ejhaem|January 31, 2023
Supply chain disruptions due to the SARS-CoV-2 pandemic lead to an unusual preanalytical error in measuring hemoglobin concentration in a large medical centerSamuel M Law, Rochelle Hardy, Danna Anderson, et al.
Ejhaem|July 21, 2025
Isolated Mu Heavy Chain Deposition Disease-A Rare Cause of Spontaneous Splenic Rupture in a Young AdultSwe Swe Hlaing, Gabor Varadi, Alexi Bloom, et al.
Ejhaem|November 24, 2025
Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple MyelomaGrace M Ferri, Cenk Yildirim, Nhan V Do, et al.
Ejhaem|November 28, 2025
Alternative 5-Azacitidine 5-Day 100 mg/m<sup>2</sup> Dosage Shows Non-Inferiority to Classical Schedule for Myelodysplastic Neoplasm (MDS) and Chronic Myelomonocytic Leukaemia (CMML) TreatmentGerasimos Tsilimidos, Filipe Martins, Mariangela Costanza, et al.
Ejhaem|November 3, 2025
T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia After CAR-T TherapyNobuhisa Takahashi, Kazuhiro Mochizuki, Tomoko Waragai, et al.
Ejhaem|October 27, 2025
Epcoritamab for Relapsed/Refractory EBV+ Post-Transplant Lymphoproliferative Disorder of DLBCL-TypeLi Yuan Chan, Simon O'Connor, Dima El-Sharkawi, et al.
Ejhaem|October 27, 2025
Successful Treatment of Refractory IgA-Mediated Autoimmune Hemolytic Anemia With BortezomibSilvia Neri, Corien L Eckhardt, Boukje M Beuger, et al.
Ejhaem|October 23, 2025
Correction to "Targeted Degradation of Class 1 HDACs With PROTACs is Highly Effective at Inducing DLBCL Cell Death"
Ejhaem|October 30, 2025
Secondary Malignancies Following CAR T-Cell Therapy for B-Cell Malignancies: A Retrospective AnalysisJoanne Britto, Audrey Y H Dong, Gregory Pond, et al.
Ejhaem|October 6, 2025
Insights Into Hemoglobinopathies in Spain: A Comprehensive ReviewJoan-Lluis Vives Corrons
Pageof 137